Leap Therapeutics (LPTX) Short Interest Ratio & Short Volume $3.74 -0.43 (-10.31%) (As of 10/31/2024 ET) Add Compare Share Share Short Interest Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesOptions ChainOwnershipSEC FilingsShort InterestTrends Leap Therapeutics Short Interest DataLeap Therapeutics (LPTX) has a short interest of 723,500 shares, representing 2.43% of the float (the number of shares available for trading by the public). This marks a -19.53% decrease in short interest from the previous month. The short interest ratio (days to cover) is 4.9, indicating that it would take 4.9 days of the average trading volume of 235,906 shares to cover all short positions.Current Short Interest723,500 sharesPrevious Short Interest899,100 sharesChange Vs. Previous Month-19.53%Dollar Volume Sold Short$1.66 millionShort Interest Ratio4.9 Days to CoverLast Record DateOctober 15, 2024Outstanding Shares25,600,000 sharesFloat Size29,730,000 sharesShort Percent of Float2.43%Today's Trading Volume553,598 sharesAverage Trading Volume235,906 sharesToday's Volume Vs. Average235% Short Selling Leap Therapeutics? Sign up to receive the latest short interest report for Leap Therapeutics and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort Interest ChartDays to Cover ChartShort Percent of Float ChartLPTX Short Interest Over TimeLPTX Days to Cover Over TimeLPTX Percentage of Float Shorted Over Time Ad WealthPressThis Bull Market Indicator called NVDA at $116Every now and again we find an investment idea so incredible we can’t help but share. And today is one of those rare days… Except, today we won't be giving you insight on any one particular stock… But rather, insight on a revolutionary new stock picking indicator… In fact, within the last year, this indicator has become famous for a multitude of reasons… But one of the biggest was because of the buy signal it issued on October 18th, 2022. In fact, on that very day, it said to buy NVDA at $116.37… Anyone who did would be sitting on a tremendously large return today… But even if you missed the original buy signal from October, this incredible indicator issued 11 other buy signals while Nvidia made its epic run…All you have to do is follow this link here Leap Therapeutics Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 10/15/2024723,500 shares $1.66 million -19.5%2.4%4.9 $2.29 9/30/2024899,100 shares $2.31 million -11.0%3.0%7.8 $2.57 9/15/20241,010,000 shares $2.77 million -2.9%3.4%8.4 $2.74 8/31/20241,040,000 shares $3.02 million -15.5%3.5%8.9 $2.90 8/15/20241,230,000 shares $3.03 million +17.1%4.1%9.2 $2.46 7/31/20241,050,000 shares $2.25 million -7.1%3.5%7.2 $2.14 Get the Latest News and Ratings for LPTX and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Leap Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 7/15/20241,130,000 shares $2.46 million +6.6%3.8%6.8 $2.18 6/30/20241,060,000 shares $2.08 million -14.5%3.6%3.6 $1.96 6/15/20241,240,000 shares $2.62 million -3.1%4.2%4.2 $2.11 5/31/20241,280,000 shares $3.11 million -5.2%5.0%4.3 $2.43 5/15/20241,350,000 shares $3.78 million -0.7%5.3%4.4 $2.80 4/30/20241,360,000 shares $4.22 million -6.2%5.6%4.5 $3.10 4/15/20241,450,000 shares $4.35 million +27.2%6.2%4.5 $3.00 3/31/20241,140,000 shares $3.03 million +0.9%4.9%4.7 $2.66 3/15/20241,130,000 shares $2.50 million -3.4%4.8%4.4 $2.21 2/29/20241,170,000 shares $3.26 million +4.5%5.0%4.4 $2.79 2/15/20241,120,000 shares $3.66 million +74.8%4.8%4 $3.27 1/31/2024640,800 shares $1.92 million +7.3%2.7%2.2 $3.00 1/15/2024597,400 shares $2.10 million +5.3%2.5%2.3 $3.51 12/31/2023567,300 shares $2.35 million +2.9%2.4%2.4 $4.15 12/15/2023551,200 shares $1.67 million -2.2%2.4%1.8 $3.03 11/30/2023563,600 shares $1.27 million -29.4%2.4%2 $2.25 11/15/2023798,100 shares $1.28 million +7.2%3.4%2.9 $1.60 10/31/2023744,200 shares $1.09 million +24.6%3.2%3.1 $1.47 10/15/2023597,500 shares $908,200.00 -15.1%2.5%2 $1.52 9/30/2023703,400 shares $970,692.00 +2.7%3.0%2.1 $1.38 9/15/2023684,800 shares $1.08 million +1.9%2.9%2.7 $1.57 8/31/2023671,800 shares $1.50 million -3.2%3.2%2.6 $2.23 8/15/2023694,300 shares $1.76 million -5.3%3.3%2.7 $2.54 7/31/2023732,800 shares $2.01 million -36.3%7.5%2.9 $2.74 7/15/20231,150,000 shares $3.62 million +3.6%12.0%6.4 $3.15 6/30/20231,110,000 shares $3.47 million +6.7%11.6%7.9 $3.13 6/15/20231,040,000 shares $6.29 million -89.8%10.8%8.6 $6.05 5/31/202310,230,000 shares $9.10 million -11.2%N/A10.5 $0.89 5/15/202311,520,000 shares $5.18 million +0.1%N/A14.7 $0.45 4/30/202311,510,000 shares $4.50 million No ChangeN/A19.4 $0.39 4/15/202311,510,000 shares $4.52 million +1.1%N/A16.3 $0.39 3/31/202311,390,000 shares $3.87 million +20.0%N/A15.8 $0.34 3/15/20239,490,000 shares $3.92 million +5.8%N/A12.2 $0.41 2/28/20238,970,000 shares $5.11 million +45.2%N/A12.3 $0.57Don’t Miss Out! Get 2 Hot AI Stocks for Under $10/Share 🚀 (Ad)Artificial Intelligence (AI) stocks are booming, and now is your chance to get in on the action — without breaking the bank! We’ve just uncovered 2 must-buy AI stocks trading for under $10/share, and they’re showing serious potential for growth.Click here to get your FREE report delivered instantly! 2/15/20236,180,000 shares $3.72 million +22.1%N/A8.5 $0.60 1/31/20235,060,000 shares $3.36 million +15.0%N/A6.2 $0.67 1/15/20234,400,000 shares $2.56 million +57.1%N/A5.5 $0.58 12/30/20222,800,000 shares $1.26 million +27.3%N/A4.6 $0.45 12/15/20222,200,000 shares $1.10 million -1.4%N/A3.9 $0.50 11/30/20222,230,000 shares $1.35 million -6.3%N/A3.6 $0.60 11/15/20222,380,000 shares $1.67 million -32.6%N/A3.5 $0.70 10/31/20223,530,000 shares $3.00 million +10.3%N/A5.1 $0.85 10/15/20223,200,000 shares $2.82 million +10.7%N/A5.3 $0.88 9/30/20222,890,000 shares $2.54 million +10.7%N/A4.7 $0.88 9/15/20222,610,000 shares $3.08 million No ChangeN/A3.9 $1.18 8/31/20222,610,000 shares $3.71 million +6.5%N/A4.1 $1.42 8/15/20222,450,000 shares $3.50 million -70.6%N/A3.9 $1.43 7/31/20228,340,000 shares $8.67 million -37.4%N/A12.1 $1.04 7/15/202213,320,000 shares $14.52 million -1.4%N/A18.1 $1.09 6/30/202213,510,000 shares $15.54 million -1.0%N/A17 $1.15 6/15/202213,650,000 shares $13.92 million -1.1%N/A17.2 $1.02 5/31/202213,800,000 shares $14.90 million -1.9%N/A17.8 $1.08 5/15/202214,070,000 shares $18.43 million No ChangeN/A18.7 $1.31 4/30/202214,070,000 shares $18.15 million +1.2%N/A17.3 $1.29 4/15/202213,910,000 shares $22.12 million -0.1%N/A13.6 $1.59 3/31/202213,930,000 shares $24.38 million +0.4%N/A10.7 $1.75 3/15/202213,880,000 shares $23.32 million No ChangeN/A8.8 $1.68 2/28/202213,880,000 shares $27.62 million -2.3%N/A8 $1.99 2/15/202214,200,000 shares $34.08 million +4.1%N/A7.4 $2.40 1/31/202213,640,000 shares $26.46 million -8.1%N/A7 $1.94 1/15/202214,840,000 shares $42.15 million +12.9%N/A7.7 $2.84 12/31/202113,150,000 shares $42.61 million +12.9%N/A6.7 $3.24 12/15/202111,650,000 shares $29.13 million +12.8%N/A4.3 $2.50 11/30/202110,330,000 shares $26.96 million +3.8%N/A1.6 $2.61 11/15/20219,950,000 shares $23.88 million -5.8%N/A1.6 $2.40 10/29/202110,560,000 shares $29.46 million -1.5%N/A1.7 $2.79 10/15/202110,720,000 shares $33.77 million -6.1%N/A1.8 $3.15 9/30/202111,410,000 shares $45.75 million +152.4%N/A2.1 $4.01 9/15/20214,520,000 shares $8.72 million +99.1%9.8%1 $1.93 8/31/20212,270,000 shares $3.90 million +33.5%4.9%4 $1.72 8/13/20211,700,000 shares $2.86 million +39.3%3.7%4.3 $1.68 7/30/20211,220,000 shares $1.73 million -0.8%2.7%3.4 $1.42 7/15/20211,230,000 shares $1.72 million -2.4%2.7%4.1 $1.40 6/30/20211,260,000 shares $2.07 million +2.4%2.8%3.6 $1.64 6/15/20211,230,000 shares $2.19 million +8.9%2.7%3.1 $1.78 5/28/20211,130,000 shares $1.83 million -4.2%2.5%2 $1.62 5/14/20211,180,000 shares $1.75 million -21.9%N/A2 $1.48 4/30/20211,510,000 shares $2.57 million +2.7%N/A2 $1.70 4/15/20211,470,000 shares $2.56 million -7.6%N/A1.7 $1.74 3/31/20211,590,000 shares $2.93 million +12.0%N/A1.8 $1.84 3/15/20211,420,000 shares $3.39 million +16.4%N/A1.3 $2.39 2/26/20211,220,000 shares $3.00 million +15.1%N/A1.2 $2.46 2/12/20211,060,000 shares $2.92 million +13.7%N/A1.1 $2.75 1/29/2021932,600 shares $2.15 million -23.6%N/A0.9 $2.31Don’t Miss Out! Get 2 Hot AI Stocks for Under $10/Share 🚀 (Ad)Artificial Intelligence (AI) stocks are booming, and now is your chance to get in on the action — without breaking the bank! We’ve just uncovered 2 must-buy AI stocks trading for under $10/share, and they’re showing serious potential for growth.Click here to get your FREE report delivered instantly! 1/15/20211,220,000 shares $2.71 million +13.0%N/A1.3 $2.22 12/31/20201,080,000 shares $2.39 million +38.8%N/A1.2 $2.21 12/15/2020778,400 shares $1.43 million +24.3%N/A0.9 $1.84 11/30/2020626,300 shares $995,817.00 +8.2%N/A1 $1.59 11/15/2020579,000 shares $926,400.00 +3.0%N/A1 $1.60 10/30/2020562,200 shares $1.11 million +4.6%N/A1.1 $1.98 10/15/2020537,700 shares $1.15 million -34.6%N/A1.1 $2.13 9/30/2020821,800 shares $1.63 million -5.3%N/A1.2 $1.98 9/15/2020868,100 shares $1.66 million +6.3%N/A1.1 $1.91 8/31/2020816,400 shares $1.42 million -10.2%N/A0.9 $1.74 8/14/2020908,900 shares $1.73 million -13.4%N/A1 $1.90 7/31/20201,050,000 shares $2.15 million -16.0%N/A1.2 $2.05 7/15/20201,250,000 shares $2.26 million +5.0%N/A1.6 $1.81 6/30/20201,190,000 shares $2.59 million -16.8%N/A2.2 $2.18 6/15/20201,430,000 shares $3.62 million +5.2%N/A3.3 $2.53 5/29/20201,360,000 shares $3.22 million -2.9%6.4%4.7 $2.37 5/15/20201,400,000 shares $3.21 million -2.1%6.6%4.3 $2.29 4/30/20201,430,000 shares $3.13 million +32.4%6.7%3.3 $2.19 4/15/20201,080,000 shares $1.92 million -4.4%5.1%2 $1.78 3/31/20201,130,000 shares $2.71 million -35.2%5.3%1.9 $2.40 3/13/20201,742,400 shares $2.94 million -5.3%12.0%3.2 $1.69 2/28/20201,840,000 shares $2.41 million +21.9%12.7%2.2 $1.31 2/14/20201,510,000 shares $3.35 million -7.9%10.4%1.9 $2.22 1/31/20201,640,000 shares $4.41 million +41.4%11.3%2.4 $2.69 1/15/20201,160,000 shares $2.47 million +23.1%8.0%1.8 $2.13 12/31/2019942,100 shares $1.79 million +1.9%6.5%1.8 $1.90 LPTX Short Interest - Frequently Asked Questions What is Leap Therapeutics' current short interest? Short interest is the volume of Leap Therapeutics shares that have been sold short but have not yet been closed out or covered. As of October 15th, investors have sold 723,500 shares of LPTX short. 2.43% of Leap Therapeutics' shares are currently sold short. Learn More on Leap Therapeutics' current short interest. What is a good short interest ratio for Leap Therapeutics? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. LPTX shares currently have a short interest ratio of 5.0. Learn More on Leap Therapeutics's short interest ratio. What is a good short interest percentage for Leap Therapeutics? Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 2.43% of Leap Therapeutics' floating shares are currently sold short. Is Leap Therapeutics' short interest increasing or decreasing? Leap Therapeutics saw a decline in short interest in October. As of October 15th, there was short interest totaling 723,500 shares, a decline of 19.5% from the previous total of 899,100 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. What is Leap Therapeutics' float size? Leap Therapeutics currently has issued a total of 25,600,000 shares. Some of Leap Therapeutics' outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. Leap Therapeutics currently has a public float of 29,730,000 shares. How does Leap Therapeutics' short interest compare to its competitors? 2.43% of Leap Therapeutics' shares are currently sold short. Here is how the short interest of companies compare to Leap Therapeutics: ProPhase Labs, Inc. (1.08%), Tonix Pharmaceuticals Holding Corp. (3.98%), Foghorn Therapeutics Inc. (4.65%), REGENXBIO Inc. (10.13%), Ginkgo Bioworks Holdings, Inc. (22.23%), Contineum Therapeutics, Inc. (6.73%), COMPASS Pathways plc (8.50%), Biomea Fusion, Inc. (29.18%), 4D Molecular Therapeutics, Inc. (18.26%), GH Research PLC (5.85%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: Charter Communications, Inc. ($4.14 billion), AppLovin Co. ($3.15 billion), Paychex, Inc. ($2.69 billion), Nu Holdings Ltd. ($2.48 billion), Cencora, Inc. ($2.24 billion), International Paper ($2.04 billion), Tractor Supply ($1.96 billion), Coinbase Global, Inc. ($1.93 billion), Moderna, Inc. ($1.91 billion), and SoFi Technologies, Inc. ($1.84 billion). View all of the most shorted stocks. What does it mean to sell short Leap Therapeutics stock? Short selling LPTX is an investing strategy that aims to generate trading profit from Leap Therapeutics as its price is falling. LPTX shares are trading down $0.43 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Leap Therapeutics? A short squeeze for Leap Therapeutics occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of LPTX, which in turn drives the price of the stock up even further. How often is Leap Therapeutics' short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including LPTX, twice per month. The most recent reporting period available is October, 15 2024. More Short Interest Resources from MarketBeat Related Companies ProPhase Labs Short Interest Tonix Pharmaceuticals Short Interest Foghorn Therapeutics Short Interest REGENXBIO Short Interest Ginkgo Bioworks Short Interest Contineum Therapeutics Short Interest COMPASS Pathways Short Interest Biomea Fusion Short Interest 4D Molecular Therapeutics Short Interest GH Research Short Interest Short Interest Tools Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:LPTX) was last updated on 10/31/2024 by MarketBeat.com Staff From Our PartnersTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | Sponsoredtop AI stock (it’s not MSFT, GOOGL, AMZN or AAPL)AI was by far the biggest tech investing trend right now. But Ross Givens says the #1 artificial intelligen...Traders Agency | SponsoredNvidia is Pivoting to Solve Big Tech’s $1 Trillion ProblemTaiwan Semiconductor, a partner of Nvidia’s for more than two decades, has seen its shares explode as much as ...Weiss Ratings | Sponsored“Buffett Indicator” Predicts 62% Stock Market CrashThe last time the "Buffett Indicator" flashed this red was in 2000 - right before the market crashed 50%.Behind the Markets | SponsoredTrump or Kamala? It may come down to this strange twist…Could this be the key to America's second coming? A strange resurrection born in the hollers of Appalachia? ...Porter & Company | Sponsored625,000% GainThe recent pullback in the crypto markets has left many investors in full-on panic mode, convinced the bull ru...Crypto Swap Profits | SponsoredGold at $2,600... But This Stock Gives You More for Under $20Gold just soared over $2,600 an ounce. But what if I told you there's a way to get exposure to MORE than an...Monument Traders Alliance | SponsoredCNBC’s ‘Prophet’ issues urgent Fed warning"How I 6X-ed my wife's 401K in 1 year" At the peak of the dot-com boom, a former hedge fund manager put all...Stansberry Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Leap Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Leap Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
